YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Obama vs the Drug Industry


June 20, 2013 | Earlier this week, a Forbes commentary by John Osborn outlined what the Obama administration "really thinks" about the biopharmaceutical industry. It's not flattering. Osborn says much of the problem lies in a "lingering misimpression" of how drugs are developed. Derek Lowe, blogger at In the Pipeline, offers to spell it out, and highlights his concerns with the administration's stance.
View Next Related Story
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.